Omega-3脂肪酸与缺血性卒中及其亚型的关联:3个美国队列研究
该研究基于3个美国队列(CHS、NHS、HPFS),测量基线循环磷脂脂肪酸,前瞻性分析二十碳五烯酸(EPA)、二十二碳五烯酸(DPA)和二十二碳六烯酸(DHA)与总缺血性卒中及其亚型的关联。中位随访期间共发生953例缺血性卒中,经多变量调整后,DPA和DHA水平较高与总缺血性卒中风险降低相关,DHA与动脉粥样硬化血栓性卒中风险降低相关,DPA与心源性栓塞性卒中风险降低相关。
要点
- DPA最高四分位组与最低组相比,总缺血性卒中风险降低(HR 0.74,95%CI 0.58-0.92)。
- DHA最高四分位组与最低组相比,动脉粥样硬化血栓性卒中风险降低(HR 0.53,95%CI 0.34-0.83)。
- DPA最高四分位组与最低组相比,心源性栓塞性卒中风险降低(HR 0.58,95%CI 0.37-0.92)。
核心结论
- 较高循环DHA水平与动脉粥样硬化血栓性卒中风险降低相关。
- 较高循环DPA水平与心源性栓塞性卒中风险降低相关。
- EPA与总缺血性卒中风险无显著关联(HR 0.94,95%CI 0.77-1.19)。
研究设计与样本
- 研究纳入3个美国队列:CHS、NHS和HPFS。
- 基线测量循环磷脂脂肪酸,前瞻性判定缺血性卒中及其亚型。
- 采用Cox比例风险模型(CHS)或条件logistic回归(NHS、HPFS)分析。
- 共识别953例缺血性卒中(408例动脉粥样硬化血栓性、256例心源性栓塞性、289例未分型)。
- 中位随访时间:CHS为11.2年,NHS和HPFS合并为8.3年。
主要发现
- DPA最高 versus 最低四分位:总缺血性卒中HR 0.74(95%CI 0.58-0.92)。
- DHA最高 versus 最低四分位:总缺血性卒中HR 0.80(95%CI 0.64-1.00)。
- DHA最高 versus 最低四分位:动脉粥样硬化血栓性卒中HR 0.53(95%CI 0.34-0.83)。
- DPA最高 versus 最低四分位:心源性栓塞性卒中HR 0.58(95%CI 0.37-0.92)。
- 各队列结果与合并分析结果一致。
临床怎么用
- 检测循环DPA和DHA水平可能有助于评估缺血性卒中及其亚型风险。
- 针对不同卒中亚型,Omega-3脂肪酸的预防策略可能需差异化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: The associations of individual long-chain n-3 polyunsaturated fatty acids with incident ischemic stroke and its main subtypes are not well established. We aimed to investigate prospectively the relationship of circulating eicosapentaenoic acid, docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) with risk of total ischemic, atherothrombotic, and cardioembolic stroke. METHODS: We measured circulating phospholipid fatty acids at baseline in 3 separate US cohorts: CHS (Cardiovascular Health Study), NHS (Nurses' Health Study), and HPFS (Health Professionals Follow-Up Study). Ischemic strokes were prospectively adjudicated and classified into atherothrombotic (large- and small-vessel infarctions) or cardioembolic by imaging studies and medical records. Risk according to fatty acid levels was assessed using Cox proportional hazards (CHS) or conditional logistic regression (NHS, HPFS) according to study design. Cohort findings were pooled using fixed-effects meta-analysis. RESULTS: A total of 953 incident ischemic strokes were identified (408 atherothrombotic, 256 cardioembolic, and 289 undetermined subtypes) during median follow-up of 11.2 years (CHS) and 8.3 years (pooled, NHS and HPFS). After multivariable adjustment, lower risk of total ischemic stroke was seen with higher DPA (highest versus lowest quartiles; pooled hazard ratio [HR], 0.74; 95% confidence interval [CI], 0.58-0.92) and DHA (HR, 0.80; 95% CI, 0.64-1.00) but not eicosapentaenoic acid (HR, 0.94; 95% CI, 0.77-1.19). DHA was associated with lower risk of atherothrombotic stroke (HR, 0.53; 95% CI, 0.34-0.83) and DPA with lower risk of cardioembolic stroke (HR, 0.58; 95% CI, 0.37-0.92). Findings in each individual cohort were consistent with pooled results. CONCLUSIONS: In 3 large US cohorts, higher circulating levels of DHA were inversely associated with incident atherothrombotic stroke and DPA with cardioembolic stroke. These novel findings suggest differential pathways of benefit for DHA, DPA, and eicosapentaenoic acid.
引用
- Saber H, Yakoob MY, Shi P, et al. Omega-3 Fatty Acids and Incident Ischemic Stroke and Its Atherothrombotic and Cardioembolic Subtypes in 3 US Cohorts. Stroke. 2017. PMID: 28830976. doi:10.1161/STROKEAHA.117.018235
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。